International Clinical Trial: Efficacy and Safety of 755-nm picosecond alexandrite laser with 5-mm diffractive lens array for Treating Partial Unilateral Lentiginosis: A multicenter,randomized, single-Blind, split-Lesion controlled study

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121787) titled 'Efficacy and Safety of 755-nm picosecond alexandrite laser with 5-mm diffractive lens array for Treating Partial Unilateral Lentiginosis: A multicenter,randomized, single-Blind, split-Lesion controlled study' on April 2.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Dematology Hospital of Southern Medical University

Condition: Partial Unilateral Lentiginosis

Intervention: Zoom lens array treatment group:755-nm picosecond alexandrite laser with Zoom lens array for Treating primary localized cutaneous amyloidosis

Recruitment Status: Not Recruiting

Phase: N/A

Date of First En...